Literature DB >> 9393882

The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors.

M Sattler1, R Salgia, G Shrikhande, S Verma, J L Choi, L R Rohrschneider, J D Griffin.   

Abstract

We report here that interleukin-3 (IL-3) and erythropoietin (EPO) induce formation of a complex composed of two SH2-containing phosphatases, the tyrosine phosphatase SHP-2 and the SH2 containing inositol 5-phosphatase (SHIP). Both SHP-2 and SHIP are known to be involved in growth factor signal transduction, but their potential interaction in the same pathway is novel. SHIP has previously been shown to associate with SHC, and potentially to be involved in regulating apoptosis. In contrast, in some model systems, SHP-2 has been demonstrated to positively regulate cell growth. Both phosphatases in the complex were tyrosine phosphorylated, and the amount of SHIP coprecipitating with SHP-2 was inversely related to the amount of SHIP coprecipitating with SHC. In hematopoietic cells transformed by the BCR/ABL oncogene, this phosphatase complex was found to be constitutively present with both components heavily tyrosine phosphorylated. Also, other proteins were detected in the complex, including BCR/ABL itself and c-CBL. However, transformation by BCR/ABL was associated with a reduced SHIP protein expression, which could further affect the accumulation of various inositol polyphosphates in these leukemic cells. These data suggest that the function of SHIP and SHP-2 in normal cells are linked and that BCR/ABL alters the function of this signaling complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393882     DOI: 10.1038/sj.onc.1201422

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells.

Authors:  Simrit Parmar; Jessica Smith; Antonella Sassano; Shahab Uddin; Efstratios Katsoulidis; Beata Majchrzak; Suman Kambhampati; Elizabeth A Eklund; Martin S Tallman; Eleanor N Fish; Leonidas C Platanias
Journal:  Blood       Date:  2005-03-24       Impact factor: 22.113

2.  SH2-containing inositol 5'-phosphatase inhibits transformation of Abelson murine leukemia virus.

Authors:  Shawn P Fessler; Naomi Rosenberg; Linda B Baughn
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

3.  BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis.

Authors:  M Sattler; S Verma; C H Byrne; G Shrikhande; T Winkler; P A Algate; L R Rohrschneider; J D Griffin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

4.  SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl.

Authors:  Jing Chen; Wen-Mei Yu; Hanako Daino; Hal E Broxmeyer; Brian J Druker; Cheng-Kui Qu
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

5.  Rapid ubiquitination of Syk following GPVI activation in platelets.

Authors:  Carol A Dangelmaier; Patricia G Quinter; Jianguo Jin; Alexander Y Tsygankov; Satya P Kunapuli; James L Daniel
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

6.  Altered responsiveness to chemokines due to targeted disruption of SHIP.

Authors:  C H Kim; G Hangoc; S Cooper; C D Helgason; S Yew; R K Humphries; G Krystal; H E Broxmeyer
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

7.  Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia.

Authors:  Rongzhen Xu; Yingzi Yu; Shu Zheng; Xiaoying Zhao; Qinghua Dong; Zhiwen He; Yun Liang; Qinghua Lu; Yongmin Fang; Xiaoxian Gan; Xiaohua Xu; Suzhan Zhang; Qi Dong; Xiaohong Zhang; Gen-Sheng Feng
Journal:  Blood       Date:  2005-07-19       Impact factor: 22.113

8.  Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span.

Authors:  C D Helgason; J E Damen; P Rosten; R Grewal; P Sorensen; S M Chappel; A Borowski; F Jirik; G Krystal; R K Humphries
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

9.  Suppression of interferon (IFN)-inducible genes and IFN-mediated functional responses in BCR-ABL-expressing cells.

Authors:  Efstratios Katsoulidis; Antonella Sassano; Beata Majchrzak-Kita; Nathalie Carayol; Patrick Yoon; Alison Jordan; Brian J Druker; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2008-02-20       Impact factor: 5.157

10.  SHP-2 is a novel target of Abl kinases during cell proliferation.

Authors:  Sayan Mitra; Carol Beach; Gen-Sheng Feng; Rina Plattner
Journal:  J Cell Sci       Date:  2008-09-30       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.